Total Payments
$2,405
2024 Payments
$566.79
Companies
30
Transactions
127
Medicare Patients
9,695
Medicare Billing
$461,706
Payment Breakdown by Category
Food & Beverage$2,405 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,405 | 127 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $377.18 | 24 | $0 (2024) |
| PFIZER INC. | $366.45 | 13 | $0 (2022) |
| GlaxoSmithKline, LLC. | $298.49 | 17 | $0 (2024) |
| ABBVIE INC. | $165.30 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $144.59 | 2 | $0 (2024) |
| Amgen Inc. | $124.33 | 9 | $0 (2024) |
| Lilly USA, LLC | $99.35 | 7 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $92.96 | 5 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $82.32 | 4 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $77.94 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $566.79 | 31 | GlaxoSmithKline, LLC. ($145.35) |
| 2023 | $406.95 | 17 | AstraZeneca Pharmaceuticals LP ($129.28) |
| 2022 | $516.76 | 31 | Novo Nordisk Inc ($117.69) |
| 2021 | $331.17 | 21 | Novo Nordisk Inc ($68.93) |
| 2020 | $36.53 | 3 | Welch Allyn ($12.77) |
| 2019 | $350.89 | 17 | PFIZER INC. ($157.34) |
| 2018 | $195.64 | 7 | PFIZER INC. ($133.59) |
All Payment Transactions
127 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: VACCINES | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: Inflammation | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Gastroenterology | ||||||
| 09/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: RESPIRATORY | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: RESPIRATORY | ||||||
| 08/27/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Endocrinology | ||||||
| 08/26/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $3.79 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.12 | General |
| Category: Cardio-renal | ||||||
| 07/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: NEUROSCIENCE | ||||||
| 07/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $33.06 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Cardio-renal | ||||||
| 05/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.02 | General |
| Category: NEUROSCIENCE | ||||||
| 05/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: RESPIRATORY | ||||||
| 04/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Diabetes | ||||||
| 04/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Endocrinology | ||||||
| 04/17/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Cardio-renal | ||||||
| 04/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: NEUROSCIENCE | ||||||
| 04/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: RESPIRATORY | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.14 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 47 | 2,906 | 4,145 | $379,204 | $146,324 |
| 2022 | 54 | 2,630 | 3,863 | $342,631 | $129,755 |
| 2021 | 47 | 2,240 | 3,446 | $268,706 | $110,741 |
| 2020 | 39 | 1,919 | 2,779 | $201,822 | $74,886 |
Total Patients
9,695
Total Services
14,233
Medicare Billing
$461,706
Procedure Codes
187
All Medicare Procedures & Services
187 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 218 | 508 | $116,840 | $39,995 | 34.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 168 | 168 | $55,440 | $19,918 | 35.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 56 | 56 | $26,712 | $15,496 | 58.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 159 | 159 | $36,888 | $11,730 | 31.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 65 | 65 | $5,525 | $4,675 | 84.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 75 | $11,850 | $4,186 | 35.3% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 30 | 30 | $11,310 | $3,726 | 32.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 180 | 285 | $9,120 | $3,700 | 40.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 199 | 361 | $7,581 | $3,676 | 48.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 213 | 441 | $5,984 | $3,565 | 59.6% |
| 82306 | Vitamin d-3 level | Office | 2023 | 85 | 120 | $8,280 | $3,452 | 41.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 160 | 160 | $8,000 | $2,644 | 33.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 197 | 338 | $6,422 | $2,537 | 39.5% |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | Office | 2023 | 53 | 53 | $4,240 | $2,407 | 56.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 79 | 80 | $3,760 | $2,275 | 60.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 93 | 133 | $5,320 | $2,189 | 41.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $7,634 | $2,148 | 28.1% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $5,712 | $1,836 | 32.1% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 13 | 13 | $3,198 | $1,817 | 56.8% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 33 | 42 | $4,074 | $1,699 | 41.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 56 | 56 | $2,632 | $1,564 | 59.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 79 | 132 | $3,036 | $1,202 | 39.6% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 30 | 30 | $3,450 | $1,100 | 31.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 63 | 71 | $2,556 | $1,049 | 41.1% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 40 | 55 | $2,365 | $991.10 | 41.9% |
About Dr. Albert Vaughn, MD
Dr. Albert Vaughn, MD is a Internal Medicine healthcare provider based in Jefferson City, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2014. The National Provider Identifier (NPI) number assigned to this provider is 1689084865.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Albert Vaughn, MD has received a total of $2,405 in payments from pharmaceutical and medical device companies, with $566.79 received in 2024. These payments were reported across 127 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,405).
As a Medicare-enrolled provider, Vaughn has provided services to 9,695 Medicare beneficiaries, totaling 14,233 services with total Medicare billing of $461,706. Data is available for 4 years (2020–2023), covering 187 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program, Pediatrics
- Location Jefferson City, TN
- Active Since 04/28/2014
- Last Updated 06/26/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1689084865
Products in Payments
- Ozempic (Drug) $190.55
- VRAYLAR (Drug) $165.30
- FARXIGA (Drug) $144.59
- Rybelsus (Drug) $138.21
- PREVNAR - 13 (Biological) $135.37
- TRELEGY ELLIPTA (Drug) $115.63
- TRUMENBA (Biological) $111.65
- NURTEC ODT (Drug) $82.32
- SHINGRIX (Biological) $81.64
- Kerendia (Drug) $77.94
- MOUNJARO (Drug) $73.87
- BEXSERO (Biological) $71.75
- XIFAXAN (Drug) $71.72
- ELIQUIS (Drug) $60.25
- ANDEXXA (Biological) $57.27
- EVENITY (Biological) $56.90
- GVOKE PFS (Drug) $51.56
- Dexcom G6 Transmitter (Medical Supply) $51.04
- INJECTAFER (Drug) $48.26
- CHANTIX (Drug) $43.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Jefferson City
Dr. Alan Rauba, M.d, M.D
Internal Medicine — Payments: $921,314
Internal Medicine $921,314
Dr. Christopher Case, M.d, M.D
Internal Medicine — Payments: $193,448
Internal Medicine $193,448
Dr. Thomas Schneider, M.d, M.D
Internal Medicine — Payments: $17,202
Internal Medicine $17,202
Dr. Stephen Sides, D.o, D.O
Internal Medicine — Payments: $11,660
Internal Medicine $11,660
Lorenzo Mcknelly, D.o, D.O
Internal Medicine — Payments: $10,588
Internal Medicine $10,588
John Kirby, M.d, M.D
Internal Medicine — Payments: $7,872
Internal Medicine $7,872